Hepatitis E viral loads in plasma pools for fractionation

Transfusion

Volumn 56, Issue 10, 2016, Pages 2532-2537

  Baylis, Sally A ^a   Corman, Victor M ^b   Ong, Edgar ^c   Linnen, Jeffrey M ^c   Nübling, C Micha ^a   Blümel, Johannes ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c HOLOGIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE; GENE AND NUCLEIC ACID PARAMETERS; GENOTYPE; HEPATITIS E VIRUS; NONHUMAN; PRIORITY JOURNAL; RDRP GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCREENING TEST; SEQUENCE ANALYSIS; SEROPREVALENCE; VIREMIA; VIRUS LOAD; ASIA; BLOOD; BLOOD DONOR; EUROPE; GENETICS; HEPATITIS E; HUMAN; NORTH AMERICA; PLASMA; PREVALENCE; VIROLOGY;

VIRUS RNA;

ASIA; BLOOD DONORS; EUROPE; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; NORTH AMERICA; PLASMA; PREVALENCE; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; VIRAL LOAD; VIREMIA;

EID: 84991628268     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13722     Document Type: Article

References (41)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477–88.
2. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012;367:1237–44.
3. Pauli G, Aepfelbacher M, Bauerfeind U, et al. Hepatitis E virus. Transfus Med Hemother 2015;42:247–65.
4. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44:934–40.
5. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med 2006;16:79–83.
6. Colson P, Coze C, Gallian P, et al. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007;13:648–9.
7. Matsubayashi K, Kang JH, Sakata H, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368–75.
8. Haïm-Boukobza S, Ferey MP, Vétillard AL, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012;57:1374–8.
9. Huzly D, Umhau M, Bettinger D, et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro Surveill 2014;19. pii: 20812.
10. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766–73.
11. Matsui T, Kang JH, Matsubayashi K, et al. Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: viral dynamics from onset to recovery. Hepatol Res 2015;45:698–704.
12. Adlhoch C, Kaiser M, Pauli G, et al. Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang 2009;97:303–8.
13. Sakata H, Matsubayashi K, Takeda H, et al. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 2008;48:2568–76.
14. Guo QS, Yan Q, Xiong JH, et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 2010;48:317–8.
15. Petrik J, Lozano M, Seed CR, et al. Hepatitis E. Vox Sang 2016;110:93–103.
16. Ijaz S, Szypulska R, Tettmar KI, et al. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2012;102:272
17. Baylis SA, Gärtner T, Nick S, et al. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012;103:89–90.
18. Hourfar MK, Capalbo G, Sireis W, et al. Pilot study of hepatitis E virus detection in blood donors with a multiplex mini pool NAT assay on Zelos X100 platform. 32nd International Congress of the ISBT, Cancún, Mexico, 7-12 July, 2012.
19. Vollmer T, Diekmann J, Johne R, et al. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012;50:2708–13.
20. Cleland A, Smith L, Crossan C, et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105:283–9.
21. Corman VM, Drexler JF, Eckerle I, et al. Zoonotic hepatitis E virus strains in German blood donors. Vox Sang 2013;104:179–80.
22. Slot E, Hogema BM, Riezebos-Brilman A, et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:pii: 20550.
23. Gallian P, Lhomme S, Piquet Y, et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 2014;20:1914–7.
24. Fischer C, Hofmann M, Danzer M, et al. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria. PLoS One 2015;10:e0119576
25. Sauleda S, Ong E, Bes M, et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015;55:972–9.
26. Xu C, Wang RY, Schechterly CA, et al. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients. Transfusion 2013;53:2505–11.
27. Stramer SL, Moritz ED, Foster GA, et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 2016;56:481–8.
28. Baylis SA, Koc O, Nick S, et al. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2012;102:182–3.
29. Toyoda H, Honda T, Hayashi K, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology 2008;51:21–5.
30. Andonov A, Rock G, Lin L, et al. Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma. Vox Sang 2014;107:213–9.
31. Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM). Rapport d'activité hémovigilance 2013 [Internet]. Saint-Denis, France: ANSM; September 2014 [cited 2016 Jun 27]. Available from: http://www.ansm.sante.fr/var/ansm_site/storage/original/application/8a2c3c478172fcfbe027742aed130adf.pdf.
32. Mallet V, Sberro-Soussan R, Vallet-Pichard A, et al. Transmission of hepatitis E virus by plasma exchange: a case report. Ann Intern Med 2016;164:851–2.
33. Baylis SA, Blümel J, Mizusawa S, et al. World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013;19:729–35.
34. Drexler JF, Seelen A, Corman VM, et al. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol 2012;86:9134–47.
35. Smith DB, Simmonds P, Izopet J, et al. Proposed reference sequences for hepatitis E virus subtypes. J Gen Virol 2016;97:537–42.
36. Aggarwal R. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. WHO/IVB/10.14. Geneva: World Health Organization; 2010.
37. Hogema BM, Molier M, Sjerps M, et al. Incidence and duration of hepatitis E virus infection in Dutch blood donors. Transfusion 2016;56:722–8.
38. Baylis SA, Hanschmann KM, Blümel J, et al. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011;49:1234–9.
39. Committee for Medicinal Products for Human Use (CHMP). Reflection paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus [Internet]. London: European Medicines Agency; 2015 Jun 25 [cited 2016 Jun 27]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/07/WC500189012.pdf.
40. European Pharmacopoeia 5.0. Human plasma (pooled and treated for virus inactivation), monograph 1646. Ph. Eur. 8th ed. Strasbourg: Council of Europe; 2015.
41. Modrow S, Wenzel JJ, Schimanski S, et al. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates. Vox Sang 2011;100:351–8.